Cardiology

Safety of PCSK9 Inhibitors After Heart Transplantation Examined




PCSK9 inhibitors are a potentially safe lipid-lowering therapy for heart transplant recipients with suboptimal LDL management on statins.

Source link




Related posts

Remote Left Ventricular Hemodynamic Monitoring Using a Novel Intracardiac Sensor [New Techniques]

Newsemia

Outcomes of Bioprosthetic Valves in the Pulmonary Position in Adults with Congenital Heart Disease.

Newsemia

Improving selection of MitraClip® candidates in advanced chronic heart failure. Look right to predict right.

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy